Across the recent three months, 6 analysts have shared their insights on Phreesia PHR, expressing a variety of opinions spanning from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 3 | 3 | 0 | 0 | 0 |
Last 30D | 1 | 0 | 0 | 0 | 0 |
1M Ago | 0 | 0 | 0 | 0 | 0 |
2M Ago | 0 | 1 | 0 | 0 | 0 |
3M Ago | 2 | 2 | 0 | 0 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $31.33, a high estimate of $35.00, and a low estimate of $29.00. This upward trend is evident, with the current average reflecting a 9.28% increase from the previous average price target of $28.67.
Decoding Analyst Ratings: A Detailed Look
A comprehensive examination of how financial experts perceive Phreesia is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Ryan MacDonald | Needham | Maintains | Buy | $29.00 | $29.00 |
Jessica Tassan | Piper Sandler | Raises | Overweight | $33.00 | $31.00 |
Daniel Grosslight | Citigroup | Raises | Buy | $35.00 | $31.00 |
Ryan MacDonald | Needham | Maintains | Buy | $29.00 | $29.00 |
Scott Schoenhaus | Keybanc | Raises | Overweight | $30.00 | $28.00 |
Sean Dodge | RBC Capital | Raises | Outperform | $32.00 | $24.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Phreesia. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Phreesia compared to the broader market.
- Price Targets: Delving into movements, analysts provide estimates for the future value of Phreesia's stock. This analysis reveals shifts in analysts' expectations over time.
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Phreesia's market standing. Stay informed and make well-considered decisions with our Ratings Table.
Stay up to date on Phreesia analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
About Phreesia
Phreesia Inc is a provider of comprehensive software solutions that improves the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, but not limited to, initial patient contact, registration, appointment scheduling, payments, and post-appointment patient surveys.
Phreesia's Financial Performance
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: Phreesia displayed positive results in 3 months. As of 31 October, 2024, the company achieved a solid revenue growth rate of approximately 16.57%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.
Net Margin: Phreesia's net margin is impressive, surpassing industry averages. With a net margin of -13.49%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Phreesia's ROE excels beyond industry benchmarks, reaching -5.69%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Phreesia's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -3.9%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Phreesia's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.08.
The Significance of Analyst Ratings Explained
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.